Seasonal Allergic Conjunctivitis clinical trials

Explore recruiting seasonal allergic conjunctivitis clinical trials.

Recruiting seasonal allergic conjunctivitis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Seasonal Allergic Conjunctivitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

MULTICENTRE, RANDOMISED, DOUBLE-BLIND, VEHICLE AND ACTIVE-CONTROLLED PHASE III STUDY EVALUATING THE EFFICACY AND SAFETY OF KETOTIFEN OPHTHALMIC SOLUTION 0.5 MG/ML COMPARED TO VEHICLE AND KETOFTIL (KETOTIFEN OPHTHALMIC SOLUTION 0.5 MG/ML) FOR THE TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS.

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Seasonal Allergic Conjunctivitis trials by city

Seasonal Allergic Conjunctivitis in Toronto Seasonal Allergic Conjunctivitis in Vancouver Seasonal Allergic Conjunctivitis in Montreal Seasonal Allergic Conjunctivitis in Calgary Seasonal Allergic Conjunctivitis in Edmonton Seasonal Allergic Conjunctivitis in Ottawa Seasonal Allergic Conjunctivitis in Winnipeg Seasonal Allergic Conjunctivitis in Quebec City Seasonal Allergic Conjunctivitis in Hamilton Seasonal Allergic Conjunctivitis in Kitchener Seasonal Allergic Conjunctivitis in London Seasonal Allergic Conjunctivitis in Halifax Seasonal Allergic Conjunctivitis in New York Seasonal Allergic Conjunctivitis in Los Angeles Seasonal Allergic Conjunctivitis in Chicago Seasonal Allergic Conjunctivitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease